[1] DE HAAS M,THURIK F F,KOELEWIJN J M,et al.Haemolytic disease of the fetus and newborn[J]. Vox Sang,2015,109(2):99-113. [2] LI S,HE Z M,LUO Y M,et al.Distribution of maternal red cell antibodies and the risk of severe alloimmune haemolytic disease of the foetus in a Chinese population:a cohort study on prenatal management[J]. BMC Pregnancy Childbirth,2020,20(1):539. [3] WEBB J,DELANEY M.Red blood cell alloimmunization in the pregnant patient[J]. Transfus Med Rev,2018,32(4):213-219. [4] ZONNEVELD R,VAN DER MEER-KAPELLE L,SYLVA M,et al. Severe fetal hemolysis and cholestasis due to high-titer maternal IgG anti-a antibodies[J]. Pediatrics,2019,143(4):e20182859. [5] 唐娜,佘亚辉,陈珲,等. O型血孕妇IgG抗A(B)抗体效价与新生儿溶血病和高胆红素血症关系及预测价值[J]. 中国计划生育学杂志,2023,31(6):1460-1464. [6] 王秀灵,韩燕媚,谭三阳,等. ABO新生儿溶血与O型血产妇产前抗体效价关系研究[J]. 华南预防医学,2023,49(6):696-699. [7] 薛松,徐诗雅,孙会丽. 血清学指标及溶血三项试验对新生儿溶血病早期诊断的价值[J]. 分子诊断与治疗杂志,2022,14(2):312-316. [8] 中国输血协会免疫血液学专业委员会. 胎儿新生儿溶血病实验室检测专家共识[J]. 临床输血与检验,2021,23(1):20-23. [9] CAO H J,WU R H,HAN M,et al.Oral administration of Chinese herbal medicine during gestation period for preventing hemolytic disease of the newborn due to ABO incompatibility:a systematic review of randomized controlled trials[J]. PLoS One,2017,12(7):e0180746. [10] 戚凤,王沈峰. 母婴血型不合导致新生儿溶血病的实验室检测结果分析[J]. 中国医药指南,2019,17(21):63-64. [11] 赵家宁,宋贺,马峰,等. 放散试验室内质控方法的初步探讨[J]. 临床血液学杂志,2020,33(8):534-537. [12] MATTEOCCI A,DE ROSA A,BUFFONE E,et al.Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years[J]. Transfus Med,2019,29(3):197-201. [13] 朱洁好,叶伙梅. 189例新生儿ABO溶血三项试验结果的分析[J]. 实验与检验医学,2021,39(2):472-473. [14] 陶琳,段秉政. 探讨微柱凝胶法和试管法对诊断新生儿溶血病的影响[J]. 内蒙古医学杂志,2023,55(5):535-538. [15] 栾劲,程静辉. 早期溶血试验在改善新生儿ABO溶血病预后中的效果观察[J]. 中国当代医药,2013,20(35):36-37. [16] 尹东杰,王荫红. 578例新生儿溶血病3项试验与日龄的关系分析[J]. 中国冶金工业医学杂志,2023,40(6):627-629. [17] 王莲慧,徐子恒,舒锦,等. 新生儿溶血病检测结果在临床诊断中的应用[J]. 实验与检验医学,2023,41(1):87-90. |